Psykey, Inc. (OTCMKTS:CEOS) Short Interest Down 92.0% in July

Psykey, Inc. (OTCMKTS:CEOS) was the recipient of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 2,400 shares, a drop of 92.0% from the July 15th total of 29,822 shares. Based on an average daily trading volume, of 161,424 shares, the short-interest ratio is currently 0.0 days.

Psykey Price Performance

OTCMKTS:CEOS remained flat at $0.01 during midday trading on Tuesday. 2,200 shares of the company traded hands, compared to its average volume of 180,128. The stock has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.01. Psykey has a 12-month low of $0.00 and a 12-month high of $0.01.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc and changed its name to Psykey, Inc in August 2021.